# Inflect Health

> Inflect Health is a VC fund in Emeryville backing Health Care, Medical and Software. See 20 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Emeryville, United States
- Total investments: 20
- Last investment: Oct 2025
- Lead investor: 5%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/inflecthealth
- X (Twitter): https://twitter.com/inflecthealth?lang=en
- Website: https://inflecthealth.com/

Inflect Health is a VC fund in Emeryville focused on Health Care and Medical. Inflect Health is Optimized and accessible for all.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 11 | 55% |
| Medical | 4 | 20% |
| Software | 4 | 20% |
| Artificial Intelligence | 4 | 20% |
| Machine Learning | 3 | 15% |

34 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 10 | 50% |
| Series A | 4 | 20% |
| Pre-Seed | 3 | 15% |
| Series B | 1 | 5% |
| Venture - Series Unknown | 1 | 5% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Nome Bio | Nome is the Operating System for Personalized Therapies™. Where traditional pharmaceutical infrastructure was built for mass-market drugs, Nome provides the coordination layer that rare disease programs require: AI-driven genomic assessment, regulatory navigation, researcher and manufacturer matching, and end-to-end program management — all in oneplatform.Nome serves as a tech-enabled service company sitting between the patient and the clinic. For a patient or family, Nome delivers a free therapy eligibility assessment in 1–2 weeks, followed by an execution-ready action plan. For clinicians and foundations, Nome functions as an intelligent scientific program manager — handling the orchestration complexity that has historically made personalized drug development inaccessible outside of elite academic medical centers.The platform is modality-agnostic, with current focus on antisense oligonucleotides and gene therapies. Nome also operates as a preclinical CRO, offering target design, toxicology studies, and pre-clinical manufacturing services for rare genetic diseases.Founded by Steven Ringel — a rare disease patient, former Sema4, GeneDx, and Tempus operator, and founder of the Kizuna Foundation (foundation to develop retinal gene therapies) — Nome emerged from stealth in October 2025 backed by Twelve Below, Refactor Capital, and Inflect Health. | $2.7M | Seed | Oct 15, 2025 |  |
| Junction | Nine self contained Environmental Sensors monitor conditions related to building spaces and equipmentCloud Based Analytics turns that sensor data Into real time alerts and other actionable intelligence.Open platform designed to integrate with other sensors and data sources, and combine their output at the analytical stage to create morerefined intelligence. | $18M | Series A | Mar 11, 2025 |  |
| ShiftRx | ShiftRx matches pharmacists and pharmacy technicians with facilities to find and book open pharmacy shifts on their schedules. The platform addresses short-staffing issues by allowing pharmacy providers and allied facilities to find and book per diem shifts. ShiftRx is designed to empower both pharmacists and pharmacy technicians by providingflexible work opportunities and helping facilities maintain adequate staffing levels. | $3.5M | Pre-Seed | Jul 25, 2024 |  |
| ShiftRx | ShiftRx matches pharmacists and pharmacy technicians with facilities to find and book open pharmacy shifts on their schedules. The platform addresses short-staffing issues by allowing pharmacy providers and allied facilities to find and book per diem shifts. ShiftRx is designed to empower both pharmacists and pharmacy technicians by providingflexible work opportunities and helping facilities maintain adequate staffing levels. | $3.5M | Seed | Jul 25, 2024 |  |
| Seven Starling | Seven Starling is a digital clinic uniquely focused on treatment for perinatal mental health conditions like postpartum depression and anxiety. Through a combination of individualized therapy, peer support, and medication, its evidence-based care model is backed by research that shows that 90% of patients will feel better within 3 months. | $10.9M | Series A | Jul 16, 2024 |  |
| IntuBlade | IntuBlade is a pioneering medical technology company dedicated to transforming airway management and intubation practices with innovative, AI-enabled solutions. Founded by experienced medical professionals, our flagship product is a next-generation video laryngoscope featuring patented lens-clearing technology and seamless USB-C connectivity.Designed with input from emergency physicians and anesthesiologists, IntuBlade enhances intubation success rates, reduces procedure time, and improves patient safety in critical care scenarios.By incorporating advanced technologies, including potential AI/ML integration for predictive diagnostics and training, IntuBlade addresses the challenges of traditional devices, ensuring reliable, contamination-free, and portable solutions for high-pressure environments. We are committed to continuous research and development, forging partnerships within the healthcare and defense communities to deliver life-saving tools to emergency departments, operating rooms, and battlefield settings worldwide.Our mission is to empower medical professionals with cutting-edge tools that improve patient outcomes, streamline workflows, and set new standards in airway management. | $115K | Seed | Oct 13, 2023 |  |
| Ivy Clinicians | Ivy Clinicians is the first to map the entire US emergency medicine employer market. We have made that information searchable and filterable so emergency clinicians can connect with the right in-house recruiters.Ivy is led by physicians, PAs, and entrepreneurs dedicated to improving the healthcare job market. Prior to Ivy, it was difficult forclinicians to find out which group staffs an ER, who the right contact person is, and what the working conditions are at the site. For recruiters, finding clinician matches was difficult because providers don’t have a simple, secure way to indicate interest in particular jobs and to communicate their priorities. Ivy is designed to connect clinicians with in-house recruiters so both find what they’re looking for, spam-free. Ivy Clinicians is free for physicians, PAs and nurse practitioners. Ivy charges employers less than 2% of first year salary when a clinician is hired from an Ivy match. Ivy keeps costs low, is free until a clinician is hired, and has no hidden (eg: retention) fees.Ivy is where clinicians go first. | $310K | Pre-Seed | Oct 07, 2023 |  |
| Macro Trials | Developer of a precision research clinical platform designed to bring therapeutics to market. The company provides an infrastructure to reduce the complexity of distributed trials that includes new site activation and site monitoring, enabling investigators and patients to facilitate and optimize clinical research. | $6M | Seed | Jun 21, 2023 |  |
| Karoo Health | Karoo Health is a leader in tech-enabled value-based cardiovascular care solutions and aims to bring innovative, end-to-end, cardiovascular solutions to patients via partnerships with health plans and self-insured employers. As a patient-first organization, Karoo Health’s mission is to help patients lead their best lives by providing a new paradigmof better cardiology care, at lower cost, than the current system and preventing the progression of cardiovascular disease. | $3.4M | Seed | Jun 07, 2023 |  |
| IntuBlade | IntuBlade is a pioneering medical technology company dedicated to transforming airway management and intubation practices with innovative, AI-enabled solutions. Founded by experienced medical professionals, our flagship product is a next-generation video laryngoscope featuring patented lens-clearing technology and seamless USB-C connectivity.Designed with input from emergency physicians and anesthesiologists, IntuBlade enhances intubation success rates, reduces procedure time, and improves patient safety in critical care scenarios.By incorporating advanced technologies, including potential AI/ML integration for predictive diagnostics and training, IntuBlade addresses the challenges of traditional devices, ensuring reliable, contamination-free, and portable solutions for high-pressure environments. We are committed to continuous research and development, forging partnerships within the healthcare and defense communities to deliver life-saving tools to emergency departments, operating rooms, and battlefield settings worldwide.Our mission is to empower medical professionals with cutting-edge tools that improve patient outcomes, streamline workflows, and set new standards in airway management. | $300K | Pre-Seed | Dec 13, 2022 |  |

10 of 20 investments shown.

## Co-investors
- [Lightspeed Venture Partners](https://shizune.co/investors/profile/lightspeed-venture-partners) — VC Fund, 5 deals together
- [Amino Collective](https://shizune.co/investors/profile/amino-collective) — VC Fund, 2 deals together
- [Argon Ventures](https://shizune.co/investors/profile/argon-ventures) — VC Fund, 2 deals together
- [Breyer Capital](https://shizune.co/investors/profile/breyer-capital) — VC Fund, 2 deals together
- [Gutbrain Ventures](https://shizune.co/investors/profile/gutbrain-ventures) — VC Fund, 2 deals together
- [MBX Capital](https://shizune.co/investors/profile/mbx-capital) — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Inflect Health invest in?

Inflect Health invests primarily in Health Care, Medical and Software startups, most often at Seed and Series A stage. Most of the 20 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Inflect Health last invest?

The most recent investment recorded for Inflect Health closed in Oct 2025. Shizune tracks 20 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co